BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 22965284)

  • 21. Cervical carcinoma in Southern Mexico: Human papillomavirus and cofactors.
    Illades-Aguiar B; Cortés-Malagón EM; Antonio-Véjar V; Zamudio-López N; Alarcón-Romero Ldel C; Fernández-Tilapa G; Hernández-Sotelo D; Terán-Porcayo MA; Flores-Alfaro E; Leyva-Vázquez MA
    Cancer Detect Prev; 2009; 32(4):300-7. PubMed ID: 19022588
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence of genotype-specific human papillomavirus infection and cervical neoplasia in Taiwan: a community-based survey of 10,602 women.
    Chen HC; You SL; Hsieh CY; Schiffman M; Lin CY; Pan MH; Chou YC; Liaw KL; Hsing AW; Chen CJ;
    Int J Cancer; 2011 Mar; 128(5):1192-203. PubMed ID: 20853317
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Carcinogenic HPV prevalence and age-specific type distribution in 40,382 women with normal cervical cytology, ASCUS/LSIL, HSIL, or cervical cancer: what is the potential for prevention?
    Kjær SK; Munk C; Junge J; Iftner T
    Cancer Causes Control; 2014 Feb; 25(2):179-89. PubMed ID: 24242002
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epidemiology of HPV 16 and cervical cancer in Finland and the potential impact of vaccination: mathematical modelling analyses.
    Barnabas RV; Laukkanen P; Koskela P; Kontula O; Lehtinen M; Garnett GP
    PLoS Med; 2006 May; 3(5):e138. PubMed ID: 16573364
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Psychological burden of testing positive for high-risk human papillomavirus on women with atypical cervical cytology: a prospective study.
    Kwan TT; Cheung AN; Lo SS; Lee PW; Tam KF; Chan KK; Ngan HY
    Acta Obstet Gynecol Scand; 2011 May; 90(5):445-51. PubMed ID: 21306349
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human papillomavirus infection and cervical cancer prevention in India, Bangladesh, Sri Lanka and Nepal.
    Sankaranarayanan R; Bhatla N; Gravitt PE; Basu P; Esmy PO; Ashrafunnessa KS; Ariyaratne Y; Shah A; Nene BM
    Vaccine; 2008 Aug; 26 Suppl 12():M43-52. PubMed ID: 18945413
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence of HPV types in cervical specimens from an integrated healthcare delivery system: baseline assessment to measure HPV vaccine impact.
    Dunne EF; Klein NP; Naleway AL; Baxter R; Weinmann S; Riedlinger K; Fetterman B; Steinau M; Scarbrough MZ; Gee J; Markowitz LE; Unger ER
    Cancer Causes Control; 2013 Feb; 24(2):403-7. PubMed ID: 23292130
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Determinants of cervical cancer rates in developing countries.
    Drain PK; Holmes KK; Hughes JP; Koutsky LA
    Int J Cancer; 2002 Jul; 100(2):199-205. PubMed ID: 12115570
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Breast cancer and microbial cancer incidence in female populations around the world: a surprising hyperbolic association.
    Savu A; Potter J; Li S; Yasui Y
    Int J Cancer; 2008 Sep; 123(5):1094-9. PubMed ID: 18537160
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Knowledge about human papillomavirus and prevention of cervical cancer among women of Arkhangelsk, Northwest Russia.
    Roik EE; Sharashova EE; Nieboer E; Kharkova OA; Postoev VA; Odland JØ
    PLoS One; 2017; 12(12):e0189534. PubMed ID: 29236761
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessing Geographic Variation in Rates of Cervical Cancer and Recurrent or Metastatic Cervical Cancer Among Medicaid Enrollees.
    Leath CA; Nysenbaum J; Ting J; Zhang YJ; Fiori A; Pauly N
    Am J Clin Oncol; 2023 Sep; 46(9):392-398. PubMed ID: 37459055
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thousands of Women's Lives Depend on the Improvement of Poland's Cervical Cancer Screening and Prevention Education as Well as Better Networking Strategies Amongst Cervical Cancer Facilities.
    Śniadecki M; Poniewierza P; Jaworek P; Szymańczyk A; Andersson G; Stasiak M; Brzeziński M; Bońkowska M; Krajewska M; Konarzewska J; Klasa-Mazurkiewicz D; Guzik P; Wydra DG
    Diagnostics (Basel); 2022 Jul; 12(8):. PubMed ID: 35892517
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Geographic variations in cervical cancer risk in San Luis Potosí state, Mexico: A spatial statistical approach.
    Terán-Hernández M; Ramis-Prieto R; Calderón-Hernández J; Garrocho-Rangel CF; Campos-Alanís J; Ávalos-Lozano JA; Aguilar-Robledo M
    Int J Equity Health; 2016 Sep; 15(1):161. PubMed ID: 27681081
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Consensus Report on the Prevention, Diagnosis, and Treatment of Cervical Cancer - a Perspective from the Immune System Toward Immunotherapy.
    Cetina-Pérez L; Castro-Eguiluz D
    Rev Invest Clin; 2020 May; 73(3):. PubMed ID: 32488222
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Leveraging technology to drive the NDNQI® prevalence and incidence study: Erratum.
    Nurs Manage; 2023 Sep; 54(9):1. PubMed ID: 37647562
    [No Abstract]   [Full Text] [Related]  

  • 36. Country Cancer Report.
    Xu T; Giroh L; Yu T; Sun W
    Enliven Chall Cancer Detect Ther; 2014; 1(1):. PubMed ID: 25685853
    [No Abstract]   [Full Text] [Related]  

  • 37. Impact of human papillomavirus vaccine on cervical cancer epidemic: Evidence from the surveillance, epidemiology, and end results program.
    Pei J; Shu T; Wu C; Li M; Xu M; Jiang M; Zhu C
    Front Public Health; 2022; 10():998174. PubMed ID: 36684904
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predicting Cohort-Specific Cervical Cancer Incidence From Population-Based Surveys of Human Papilloma Virus Prevalence: A Worldwide Study.
    Schulte-Frohlinde R; Georges D; Clifford GM; Baussano I
    Am J Epidemiol; 2022 Feb; 191(3):402-412. PubMed ID: 34652438
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acquisition, prevalence and clearance of type-specific human papillomavirus infections in young sexually active Indian women: A community-based multicentric cohort study.
    Muwonge R; Basu P; Gheit T; Anantharaman D; Verma Y; Bhatla N; Joshi S; Esmy PO; Poli URR; Shah A; Zomawia E; Shastri SS; Pimple S; Prabhu PR; Hingmire S; Chiwate A; Sauvaget C; Lucas E; Malvi SG; Siddiqi M; Sankaran S; Kannan TPRA; Varghese R; Divate U; Vashist S; Mishra G; Jadhav R; Tommasino M; Pillai MR; Sankaranarayanan R; Jayant K;
    PLoS One; 2020; 15(12):e0244242. PubMed ID: 33373380
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Patient Satisfaction With Human Papillomavirus Self-Sampling in a Cohort of Ethnically Diverse and Rural Women in Yunnan Province, China.
    Goldstein A; Plafker B; Stamper S; Goldstein L; Lipson R; Bedell S; Wang J; Brenner G; Goldstein G; O'Keefe K; O'Keefe C; O'Keefe M; O'Keefe T; Goldstein A; Zhao A
    J Low Genit Tract Dis; 2020 Oct; 24(4):349-352. PubMed ID: 32796262
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.